Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Total Current Liabilities (2016 - 2026)

Integra Lifesciences Holdings' Total Current Liabilities history spans 17 years, with the latest figure at $456.0 million for Q4 2025.

  • On a quarterly basis, Total Current Liabilities fell 50.55% to $456.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $456.0 million, a 50.55% decrease, with the full-year FY2025 number at $456.0 million, down 50.55% from a year prior.
  • Total Current Liabilities hit $456.0 million in Q4 2025 for Integra Lifesciences Holdings, up from $364.1 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for IART hit a ceiling of $929.8 million in Q2 2025 and a floor of $282.3 million in Q1 2023.
  • Historically, Total Current Liabilities has averaged $454.8 million across 5 years, with a median of $336.4 million in 2021.
  • The widest YoY moves for Total Current Liabilities: up 203.73% in 2025, down 60.11% in 2025.
  • Tracing IART's Total Current Liabilities over 5 years: stood at $340.0 million in 2021, then decreased by 5.62% to $320.9 million in 2022, then dropped by 4.34% to $307.0 million in 2023, then skyrocketed by 200.39% to $922.1 million in 2024, then plummeted by 50.55% to $456.0 million in 2025.
  • Business Quant data shows Total Current Liabilities for IART at $456.0 million in Q4 2025, $364.1 million in Q3 2025, and $929.8 million in Q2 2025.